Anpario plc AIM:ANP
- Incorporated
- United Kingdom
- Chief executive
- Richard Edwards
- Employees
- 158
- Reports in
- GBP
- Companies House
- 03345857
Read straight from the annual reports
510p at close on 5 Oct 2026 · 11 reported years, 2015–2025
| Line | FY201512/15 | FY201612/16 | FY201712/17 | FY201812/18 | FY201912/19 | FY202012/20 | FY202112/21 | FY202212/22 | FY202312/23 | FY202412/24 | FY202512/25 | FY2026unreported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Gross profit | ||||||||||||
| Operating profit | ||||||||||||
| Adjusted operating profit | — | — | — | |||||||||
| Exceptional items | — | |||||||||||
| Net finance cost | ||||||||||||
| Profit before tax | ||||||||||||
| Adjusted profit before tax | — | — | — | — | — | — | — | — | — | |||
| Tax charge | ||||||||||||
| Profit for the year | ||||||||||||
| EBITDA | ||||||||||||
| Adjusted minus statutory PBT | — | — | — | — | — | — | — | — | — | |||
| Basic EPS | ||||||||||||
| Diluted EPS | ||||||||||||
| Adjusted EPS | ||||||||||||
| Dividend per share |
GBP millions, negatives in brackets. Per-share lines in pence, share counts in millions. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated. The share price above is drawn to the same columns: each close sits over the financial year it fell in.
11 years, at a glance
Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
Full-year contribution from Bio-Vet Inc. (acquired 30 Sept 2024)
Bio-Vet contributed £6.7m of revenue in 2025 vs £2.2m in the three months post-acquisition in 2024
page 9Like-for-like growth across Americas, Europe and Asia
LFL sales excluding Bio-Vet up 12% to £40.5m (2024: £36.0m)
page 4Full-year Bio-Vet premium product contribution
Growth in premium products including Bio-Vet range drove gross margin up to 50.9% (2024: 46.9%)
page 9Employment cost inflation and headcount growth
LFL administrative expenses up 11% largely from wage inflation, higher UK NI, performance bonuses and increased headcount in sales/technical roles
page 9Trading to date in the current year is in line with the strong Q1 performance in the prior year; continued growth in North America and a strong start/return to growth for the Middle East region.
page 4Proposed final dividend of 8.90p per share (2024: 8.00p), giving total dividend for the year of 12.50p (2024: 11.25p), an 11% increase; payable 24 July 2026 to shareholders on the register 10 July 2026
page 5Directors adopted the going concern basis, assessed to end of March 2027; strong balance sheet with no debt and cash of £12.4m. Auditor HaysMac LLP (replacing BDO LLP during the year) issued an unqualified/true-and-fair opinion; key audit matter was valuation and recoverability of intangible assets (Brands and Developed Products, £4,480k), on which no material issues were identified; group materiality £500,000 (5% of forecast adjusted EBITDA)
page 54- Market Risk: gaining market entry, competition from global operators, M&A-driven consolidation, animal disease outbreaks, low farm profitability, commodity prices, IP theft, loss of key talent — Likelihood Medium/Impact Medium, no changep.18
- Political and Economic Risk: wars/instability, interest and inflationary pressures, FX fluctuations, FX controls, sanctions, bad debts/trade disputes — Likelihood High/Impact Medium, increasingp.18
- Product Development Risk: failure to deliver new products, failed trials, lack of R&D resource, regulatory non-compliance — Likelihood Medium/Impact Medium, reducingp.19
- Production, Quality and Logistics Risk: supply route disruption, raw material sourcing failure, quality/contamination issues, plant/line closures — Likelihood High/Impact Medium, increasingp.19
Read from C000079-AR-2025-ch.
10 annual reports read, FY2016 to FY2025
Open a year to see what its report said. Every line in it carries the page it was read from.
Sources: Companies House (10)
FY2026Next report expected 29 Mar 2027